RY 144.17 0.4529% TD 77.39 0.0517% SHOP 78.87 -1.3878% CNR 171.64 0.5625% ENB 50.09 -0.4769% CP 110.62 0.6277% BMO 128.85 -0.548% TRI 233.58 1.1563% CNQ 103.29 -0.174% BN 60.87 -0.2295% ATD 75.6 -1.447% CSU 3697.0 1.1582% BNS 65.76 -0.3485% CM 66.6 -0.5525% SU 54.21 1.1569% TRP 53.15 0.3398% NGT 58.54 -0.3405% WCN 226.5 0.4123% MFC 35.905 0.9986% BCE 46.75 -0.5954%
Last update at 2024-05-16T19:32:00Z
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Income before tax | 3.73M | 17.92M | -24.76500M | -6.98634M | -7.75868M |
| Minority interest | -12.06200M | -17.30600M | -12.89200M | 1.61M | 0.03M |
| Net income | -7.10300M | 19.07M | -30.68600M | -2.62395M | -7.79391M |
| Selling general administrative | 265.94M | 176.41M | 107.75M | 25.76M | 14.92M |
| Selling and marketing expenses | - | 47.70M | 15.78M | 1.59M | - |
| Gross profit | 351.46M | 303.29M | 153.69M | 21.22M | 10.99M |
| Reconciled depreciation | 58.11M | 55.20M | 38.22M | 4.27M | 2.16M |
| Ebit | - | 23.31M | -6.20900M | -9.89628M | -5.60747M |
| Ebitda | - | 77.31M | 32.01M | -5.62591M | -3.45242M |
| Depreciation and amortization | - | 54.00M | 38.22M | 4.27M | 2.16M |
| Non operating income net other | - | - | - | - | - |
| Operating income | 27.41M | 23.31M | -6.20900M | -9.89628M | -5.60747M |
| Other operating expenses | - | 545.15M | 310.37M | 60.65M | 38.90M |
| Interest expense | 29.97M | 22.34M | 7.55M | 1.93M | 1.45M |
| Tax provision | -1.62800M | -1.15000M | 5.92M | -4.36239M | 0.04M |
| Interest income | 0.67M | 0.65M | 2.20M | 0.45M | 0.82M |
| Net interest income | -30.18900M | -22.21400M | -7.26300M | -1.33646M | -1.20466M |
| Extraordinary items | - | - | - | - | 0.00000M |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | - | -1.15000M | 5.92M | -4.36239M | 0.04M |
| Total revenue | 701.32M | 569.14M | 302.32M | 50.24M | 32.81M |
| Total operating expenses | 673.91M | 279.31M | 161.74M | 31.62M | 17.08M |
| Cost of revenue | 349.86M | 265.85M | 148.63M | 29.02M | 21.82M |
| Total other income expense net | 6.50M | -5.39000M | -18.55600M | 2.91M | -2.15121M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 4.96M | 18.68M | -30.89500M | -3.21065M | -7.79391M |
| Net income applicable to common shares | - | 1.37M | -43.78700M | -3.68646M | -7.81875M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Total assets | 1319.03M | 1262.42M | 262.73M | 58.51M | 12.78M |
| Intangible assets | 571.27M | 405.52M | 21.23M | 24.88M | - |
| Earning assets | - | - | - | - | - |
| Other current assets | 0.52M | 3.68M | 1.50M | 0.70M | 0.32M |
| Total liab | 503.78M | 554.37M | 43.75M | 26.51M | 2.63M |
| Total stockholder equity | 732.34M | 618.24M | 217.37M | 31.97M | 10.15M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 35.72M | 75.69M | 10.10M | 6.47M | 0.22M |
| Common stock | 705.19M | 633.51M | 231.89M | 45.41M | 17.41M |
| Capital stock | 705.19M | 633.51M | 231.89M | 45.41M | - |
| Retained earnings | -63.66600M | -64.64300M | -20.82324M | -17.13678M | -8.76476M |
| Other liab | 52.12M | 72.51M | 0.92M | 0.48M | 0.33M |
| Good will | 499.29M | 611.75M | 110.12M | 13.58M | 8.46M |
| Other assets | 3.18M | 2.85M | 1.77M | 2.02M | 0.01M |
| Cash | 48.91M | 61.92M | 86.89M | 15.64M | 2.33M |
| Cash and equivalents | 48.91M | 61.92M | 86.89M | 15.64M | 2.33M |
| Total current liabilities | 136.50M | 137.30M | 22.63M | 8.38M | 0.91M |
| Current deferred revenue | 6.80M | 4.24M | 2.90M | 0.38M | - |
| Net debt | 309.51M | 340.02M | -63.32236M | 3.54M | - |
| Short term debt | 43.26M | 57.37M | 3.37M | 1.53M | 0.00000M |
| Short long term debt | 34.15M | 50.15M | 0.75M | - | - |
| Short long term debt total | 358.42M | 401.94M | 23.57M | 19.18M | - |
| Other stockholder equity | 51.77M | 43.99M | 6.37M | 3.67M | 0.02M |
| Property plant equipment | 82.53M | 88.55M | 20.89M | 12.47M | 0.27M |
| Total current assets | 150.88M | 142.91M | 103.38M | 18.88M | 7.56M |
| Long term investments | 10.01M | 10.85M | 5.35M | 0.26M | - |
| Net tangible assets | -338.21300M | -399.02800M | 86.02M | 7.09M | 6.61M |
| Short term investments | - | - | - | - | - |
| Net receivables | 95.85M | 71.82M | 8.94M | 2.47M | 0.36M |
| Long term debt | 263.00M | 290.60M | 0.95M | 4.70M | 0.00000M |
| Inventory | 1.37M | 0.79M | 1.27M | 0.06M | 0.00000M |
| Accounts payable | 50.73M | 38.67M | 6.26M | 5.44M | 0.69M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | 39.06M | 5.38M | -0.06865M | 0.02M | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | 231.89M | 45.41M | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 5.06M | 2.85M | 1.77M | 2.02M | - |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 1168.15M | 1119.52M | 159.35M | 39.64M | - |
| Capital lease obligations | 61.26M | 61.19M | 21.87M | 14.48M | - |
| Long term debt total | 315.16M | 344.57M | 20.20M | 17.65M | 0.00000M |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Investments | -82.26800M | -37.92600M | -3.12300M | -44.20817M | -10.69202M |
| Change to liabilities | - | 10.14M | 1.20M | 2.32M | 0.92M |
| Total cashflows from investing activities | - | -37.92600M | -499.77800M | -44.20817M | -10.69202M |
| Net borrowings | - | -58.75000M | 171.07M | 8.82M | 8.84M |
| Total cash from financing activities | -8.89700M | -52.84700M | 452.53M | 120.84M | 26.63M |
| Change to operating activities | - | -6.73500M | 0.21M | -0.95170M | 0.16M |
| Net income | -7.10300M | 18.68M | -30.89500M | -3.21065M | -7.79391M |
| Change in cash | -10.46400M | -13.01100M | -24.97100M | 71.25M | 13.31M |
| Begin period cash flow | 52.44M | 61.92M | 86.89M | 15.64M | 2.33M |
| End period cash flow | 42.02M | 48.91M | 61.92M | 86.89M | 15.64M |
| Total cash from operating activities | 80.75M | 76.55M | 22.27M | -5.38214M | -2.63279M |
| Issuance of capital stock | 0.00000M | 34.51M | 302.50M | 117.89M | 2.73M |
| Depreciation | 58.11M | 55.20M | 38.22M | 4.27M | 2.16M |
| Other cashflows from investing activities | - | -31.52200M | -25.54000M | -4.48092M | 0.09M |
| Dividends paid | 0.00000M | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Change to inventory | 0.06M | -0.57700M | 0.88M | -1.07524M | -0.08037M |
| Change to account receivables | - | -9.37000M | -15.20700M | -3.18503M | -0.67757M |
| Sale purchase of stock | 0.00000M | -0.24300M | 303.13M | 119.12M | 19.02M |
| Other cashflows from financing activities | - | 21.10M | 191.22M | 5.62M | 25.99M |
| Change to netincome | - | - | 37.86M | -4.18876M | 2.57M |
| Capital expenditures | 7.94M | 6.40M | 2.68M | 1.13M | 0.47M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | -6.71200M | -6.05800M | -11.19600M | -1.92109M | 0.32M |
| Stock based compensation | 24.71M | 24.48M | 21.01M | 4.97M | 2.94M |
| Other non cash items | 1.42M | -15.75700M | 5.13M | -4.62723M | -0.25150M |
| Free cash flow | 72.81M | 70.14M | 19.59M | -6.51678M | -3.10520M |
Sector: Healthcare Industry: Medical Care Facilities
| Company | Change (CAD) | Price (CAD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| WELL WELL Health Technologies Corp |
0.03 0.78% | 3.86 | - | 16.67 | 1.46 | 1.38 | 1.97 | 15.06 |
| DNTL dentalcorp Holdings Ltd |
0.17 2.63% | 6.43 | - | 16.72 | 0.92 | 0.73 | 1.84 | 12.30 |
| SIA Sienna Senior Living Inc |
-0.25 1.69% | 14.57 | - | 45.25 | 1.17 | 2.28 | 2.42 | 20.48 |
| EXE Extendicare Inc |
-0.44 5.70% | 7.28 | 34.10 | 22.37 | 0.47 | 6.25 | 0.66 | 11.11 |
| DR Medical Facilities Corporation |
0.06 0.51% | 11.92 | 30.07 | 11.61 | 0.51 | 2.15 | 0.82 | 5.32 |
WELL Health Technologies Corp. operates as a practitioner focused digital health company in Canada, the United States, and internationally. It offers omni-channel healthcare services, including primary care and allied health clinic operations; gastrointestinal, and mental disorders; specialized care, including gastroenterology anesthesia services; diagnostic services related to cardiology, women's health, and bone/muscle health and cancer diagnostics; and telehealth services. The company also operates OSCAR Pro, an electronic medical records platform; telehealth platforms, including Tia Health, VirtualClinic+, VirtuelMed, Adracare, and Circle Medical; Apps.health, a digital health app marketplace; billing and revenue cycle management solutions for billing and back-office services comprising billing-as-a-service outsourcing services to doctors; and cybersecurity protection and patient data privacy solutions. As of December 31, 2022, the company operated 90 clinics across Canada. The company was formerly known as Wellness Lifestyles Inc. and changed its name to WELL Health Technologies Corp. in July 2018. WELL Health Technologies Corp. was founded in 2010 and is headquartered in Vancouver, Canada.
375 Water Street, Vancouver, BC, Canada, V6B 5C6
| Name | Title | Year Born |
|---|---|---|
| Mr. Hamed Shahbazi B.Sc., BSc | Founder, Chairman & CEO | 1975 |
| Ms. Eva Fong | Chief Financial Officer | NA |
| Mr. Amir Javidan | Chief Operating Officer | NA |
| Mr. Brian Eric Levinkind | Sr. VP of Corp. Devel. | 1966 |
| Dr. Michael Frankel | Chief Medical Officer | NA |
| Mr. Arjun Kumar | Chief Information Officer | NA |
| Mr. Pardeep S. Sangha M.B.A. | VP of Corp. Strategy & Investor Relations | NA |
| Mr. Chris Ericksen | Sr. VP of Strategic Partnerships & Marketing | NA |
| Mr. Shane Joseph Sabatino | Chief People Officer | NA |
| Ms. Sara Bond | Sr. VP of Product Devel. | NA |
Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
CA 
AU
UK
US
NZ
Please wait processing your request...